← brief for 2026-08-30 · Slowing decline

GLP-1-BASED THERAPIES BEYOND DIABETES: EMERGING CLINICAL APPLICATIONS AND FUTURE PERSPECTIVES

Paper No results yet Peer reviewed

Key takeaways

This review maps where GLP-1 drugs, first used for diabetes and weight loss, are now being tried for other conditions. It gathers work published by others rather than running a study, so it reports no new results. These drugs are of interest to kidney patients, but this article adds no new evidence about kidneys.

Who did this work

Anna Szeszko · Małgorzata Lubowiecka · Weronika Maria Czernek · Magdalena Cichorzewska · Martyna Płachta · Rafał Wojtan

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-29
https://doi.org/10.35630/2026/16/iss.4.14